Osteomyelitis: Clinical overview and mechanisms of infection persistence

Clinical Microbiology Newsletter

Volumn 28, Issue 9, 2006, Pages 65-72

  Brady, R A ^a   Leid, J G ^b   Costerton, J W ^c   Shirtliff, M E ^a,d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NORTHERN ARIZONA UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; COTRIMOXAZOLE; GLYCOPEPTIDE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INDIUM 111; MEDRONATE TECHNETIUM TC 99M; METICILLIN; MINOCYCLINE; OXACILLIN; PENICILLIN G; RIFAMPICIN; TECHNETIUM SULFUR COLLOID TC 99M; TEICOPLANIN; VANCOMYCIN; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BIOFILM; BLOOD FLOW; BONE BIOPSY; BONE DESTRUCTION; BONE INFECTION; BONE NECROSIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANDIDA; CLEARANCE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; DIAGNOSTIC ERROR; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; GROUPS BY AGE; HAEMOPHILUS INFLUENZAE; HEMATOGENOUS OSTEOMYELITIS; HIGH RISK POPULATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; INFECTION CONTROL; INFECTION SENSITIVITY; INOCULATION; LEUKOCYTE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOBACTERIUM; ORTHOPEDIC SURGERY; OSSIFICATION; OSTEOMYELITIS; PATHOGENESIS; PERSISTENT INFECTION; PREVALENCE; PSEUDOMONAS AERUGINOSA; REMISSION; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PYOGENES; SUPERINFECTION; TISSUE CULTURE; TREATMENT DURATION; ULTRASOUND; VIRULENCE;

EID: 33646071494     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2006.04.001     Document Type: Article

References (70)

1. Mader J.T., Mohan D., and Calhoun J. A practical guide to the diagnosis and management of bone and joint infections. Drugs 54 (1997) 253
2. Shirtliff M.E., and Mader J.T. Osteomyelitis: clinical features and molecular aspects of persistence. In: Nataro J., Blaser M.J., and Cunningham-Rundles S. (Eds). Persistent bacterial infections (2000), ASM Press, Washington, D.C. 375-395
3. Waldvogel F.A., Medoff G., and Swartz M.N. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects. N. Engl. J. Med. 282 (1970) 198-206
4. Waldvogel F.A., Medoff G., and Swartz M.N. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects (second of three parts). N. Engl. J. Med. 282 (1970) 260-266
5. Waldvogel F.A., Medoff G., and Swartz M.N. Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects (third of three parts). Osteomyelitis associated with vascular insufficiency. N. Engl. J. Med. 282 (1970) 316-322
6. Espersen F., et al. Changing pattern of bone and joint infections due to Staphylococcus aureus: study of cases of bacteremia in Denmark, 1959-1988. Rev. Infect. Dis. 13 (1991) 347-358
7. Bowerman S.G., Green N.E., and Mencio G.A. Decline of bone and joint infections attributable to Haemophilus influenzae type b. Clin. Orthop. Rel. Res. 341 (1997) 128-133
8. Shirtliff M.E., Cripps M.W., and Mader J.T. Retrospective review of 728 patients with long bone osteomyelitis, abstr. c410. Am. Soc. Microbiol. 99th Gen. Meet. (1999), American Society for Microbiology, Washington, DC
9. Trueta J., and Morgan J.D. The vascular contribution to osteogenesis. Studies by the injection method. J. Bone Joint Surg. 42B (1960) 97-109
10. Hobo T. Zur pathogenese de akuten haematatogenen Osteomyelitis, mit Beruckishtigun der Vitalfarbungslehre. Acta School Med. Univ. Imp. Kioto 4 (1922) 1
11. Morrissy R.T., and Haynes D.W. Acute hematogenous osteomyelitis: a model with trauma as an etiology. J. Pediatr. Orthop. 9 (1989) 447-456
12. Jackson M.A., and Nelson J.D. Etiology and medical management of acute suppurative bone and joint infections in pediatric patients. J. Pediatr. Orthop. 2 (1982) 313-323
13. Calhoun J.H., et al. Treatment of diabetic foot infections: Wagner classification, therapy, and outcome. Foot Ankle 9 (1988) 101-106
14. Butt W.P. The radiology of infection. Clin. Orthop. 96 (1973) 20-30
15. Segall G.M., et al. The role of bone scan and radiography in the diagnostic evaluation of suspected pedal osteomyelitis. Clin. Nucl. Med. 14 (1989) 255-260
16. Wheat J. Diagnostic strategies in osteomyelitis. Am. J. Med. 78 (1985) 218-224
17. Datz F.L., et al. Decreased sensitivity of early imaging with In-111 oxine-labeled leukocytes in detection of occult infection: concise communication. J. Nucl. Med. 25 (1984) 303-306
18. Howie D.W., et al. The technetium phosphate bone scan in the diagnosis of osteomyelitis in childhood. J. Bone Joint Surg. 65 (1983) 431-437
19. Palestro C.J., et al. Diagnosis of musculoskeletal infection using combined In-111 labeled leukocyte and Tc-99m SC marrow imaging. Clin. Nucl. Med. 17 (1992) 269-273
20. Tehranzadeh J., et al. Imaging of osteomyelitis in the mature skeleton. Radiol. Clin. N. Am. 39 (2001) 223-250
21. Kothari N.A., Pelchovitz D.J., and Meyer J.S. Imaging of musculoskeletal infections. Radiol. Clin. N. Am. 39 (2001) 653-671
22. Modic M.T., et al. Vertebral osteomyelitis: assessment using MR. Radiology 157 (1985) 157
23. Carek P.J., Dickerson L.M., and Sack J.L. Diagnosis and management of osteomyelitis. Am. Fam. Physician 63 (2001) 2413
24. De Jonghe M., and Glaesener G. (Type B Haemophilus influenzae infections. Experience at the Pediatric Hospital of Luxembourg). (In French.). Bulletin Soc. Sci. Med. Grand-Duche Luxembourg 132 (1995) 17-20
25. Holzman R.S., and Bishko F. Osteomyelitis in heroin addicts. Ann. Intern. Med. 75 (1971) 693-696
26. Sapico F.L. Microbiology and antimicrobial therapy of spinal infections. Orthop. Clin. N. Am. 27 (1996) 9-13
27. Harris L.G., Foster S.J., and Richards R.G. An introduction to Staphylococcus aureus, and techniques for identifying and quantifying S. aureus adhesins in relation to adhesion to biomaterials: review. Eur. Cell Mater. 4 (2002) 39-60
28. Kluytmans J., van Belkum A., and Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10 (1997) 505-520
29. Lindsay J.A., and Holden M.T. Staphylococcus aureus: superbug, super genome?. Trends Microbiol. 12 (2004) 378-385
30. Pechous R., et al. Regulation of the expression of cell wall stress stimulon member gene msrA1 in methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 48 (2004) 3057-3063
31. Smith I.M., and Vickers A.B. Natural history of 338 treated and untreated patients with staphylococcal septicaemia. Lancet i (1960) 1318-1322
32. Foster T.J. The Staphylococcus aureus "superbug". J. Clin. Investig. 114 (2004) 1693-1696
33. Darley E.S., and MacGowan A.P. Antibiotic treatment of gram-positive bone and joint infections. J. Antimicrob. Chemother. 53 (2004) 928-935
34. Ruef C. Epidemiology and clinical impact of glycopeptide resistance in Staphylococcus aureus. Infection 32 (2004) 315
35. Regassa L.B., Novick R.P., and Betley M.J. Glucose and nonmaintained pH decrease expression of the accessory gene regulator (agr) in Staphylococcus aureus. Infect. Immun. 60 (1992) 3381-3388
36. Patel A.H., et al. Regulation of the protein A-encoding gene in Staphylococcus aureus. Gene 114 (1992) 25
37. Dassy B.T., et al. Involvement of the accessory gene regulator (agr) in expression of type 5 capsular polysaccharide by Staphylococcus aureus. J. Gen. Microbiol. 139 (1993) 1301-1306
38. Tremaine M.T., Brockman D.K., and Betley M.J. Staphylococcal enterotoxin A gene (sea) expression is not affected by the accessory gene regulator (agr). Infect. Immun. 61 (1993) 356-359
39. Chan P.F., and Foster S.J. The role of environmental factors in the regulation of virulence-determinant expression in Staphylococcus aureus 8325-4. Microbiology 144 (1998) 2469
40. Martin P.K., et al. Role in cell permeability of an essential two-component system in Staphylococcus aureus. J. Bacteriol. 181 (1999) 3666-3673
41. Chalker A.F., et al. Analysis and toxic overexpression in Escherichia coli of a staphylococcal gene encoding isoleucyl-tRNA synthetase. Gene 141 (1994) 103
42. Xiong A., et al. Molecular characterization of the ferric-uptake regulator, fur, from Staphylococcus aureus. Microbiology 146 (2000) 659
43. Gristina A.G., et al. Adherent bacterial colonization in the pathogenesis of osteomyelitis. Science 228 (1985) 990
44. Akiyama H., Torigoe R., and Arata J. Interaction of Staphylococcus aureus cells and silk threads in vitro and in mouse skin. J. Dermat. Sci. 6 (1993) 247-257
45. Herrmann M., et al. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J. Infect. Dis. 158 (1988) 693-701
46. Oie S., et al. Efficacy of disinfectants against biofilm cells of methicillin-resistant Staphylococcus aureus. Microbios 85 (1996) 223
47. Hussain M., Wilcox M.H., and White P.J. The slime of coagulase-negative staphylococci: biochemistry and relation to adherence. FEMS Microbiol. Rev. 10 (1993) 191-207
48. Akiyama H., et al. Biofilm formation of Staphylococcus aureus strains isolated from impetigo and furuncle: role of fibrinogen and fibrin. J. Environ. Pathol. Toxicol. 16 (1997) 2-10
49. Mack D., et al. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J. Bacteriol. 178 (1996) 175-183
50. Maira-Litran T., et al. Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infect. Immun. 70 (2002) 4433-4440
51. Cramton S.E., et al. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect. Immun. 67 (1999) 5427-5433
52. Cramton S.E., et al. Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect. Immun. 69 (2001) 4079-4085
53. Toledo-Arana A., et al. Staphylococcus aureus develops an alternative, ica-independent biofilm in the absence of the arlRS two-component system. J. Bacteriol. 187 (2005) 5318-5329
54. Fitzpatrick F., Humphreys H., and O'Gara J.P. Evidence for icaADBC-independent biofilm development mechanism in methicillin-resistant Staphylococcus aureus clinical isolates. J. Clin. Microbiol. 43 (2005) 1973-1976
55. Fluckiger U., et al. Biofilm formation, icaADBC transcription, and polysaccharide intercellular adhesin synthesis by staphylococci in a device-related infection model. Infect. Immun. 73 (2005) 1811-1819
56. Kiem S., et al. Phase variation of biofilm formation in Staphylococcus aureus by IS 256 insertion and its impact on the capacity adhering to polyurethane surface. J. Korean Med. Sci. 19 (2004) 779-782
57. Conlon K.M., Humphreys H., and O'Gara J.P. icaR encodes a transcriptional repressor involved in environmental regulation of ica operon expression and biofilm formation in Staphylococcus epidermidis. J. Bacteriol. 184 (2002) 4400-4408
58. Knobloch J.K., et al. Biofilm formation by Staphylococcus epidermidis depends on functional RsbU, an activator of the sigB operon: differential activation mechanisms due to ethanol and salt stress. J. Bacteriol. 183 (2001) 2624-2633
59. Jefferson K.K., et al. Identification of a 5-nucleotide sequence that controls expression of the ica locus in Staphylococcus aureus and characterization of the DNA-binding properties of IcaR. Mol Microbiol 48 (2003) 889
60. Nicholas R.O., et al. Isolation and characterization of a sigB deletion mutant of Staphylococcus aureus. Infect. Immun. 67 (1999) 3667-3669
61. Nair S.P., et al. The sigma B regulon influences internalization of Staphylococcus aureus by osteoblasts. Infect. Immun. 71 (2003) 4167-4170
62. Kullik I., and Giachino I.a.P. The alternative sigma factor sigmaB in Staphylococcus aureus: regulation of the sigB operon in response to growth phase and heat shock. Arch. Microbiol. 167 (1997) 151-159
63. Jefferson K.K., et al. The teicoplanin-associated locus regulator (TcaR) and the intercellular adhesin locus regulator (IcaR) are transcriptional inhibitors of the ica locus in Staphylococcus aureus. J. Bacteriol. 186 (2004) 2449-2456
64. Lim Y., et al. Control of glucose- and NaCl-induced biofilm formation by rbf in Staphylococcus aureus. J. Bacteriol. 186 (2004) 722-729
65. Heilmann C., et al. Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol. Microbiol. 24 (1997) 1013-1024
66. Fournier B., and Hooper D.C. A new two-component regulatory system involved in adhesion, autolysis, and extracellular proteolytic activity of Staphylococcus aureus. J. Bacteriol. 182 (2000) 3955-3964
67. Fournier B., Klier A., and Rapoport G. The two-component system ArlS-ArlR is a regulator of virulence gene expression in Staphylococcus aureus. Mol. Microbiol. 41 (2001) 247-261
68. Becker P., et al. Detection of differential gene expression in biofilm-forming versus planktonic populations of Staphylococcus aureus using micro-representational-difference analysis. Appl. Environ. Microbiol. 67 (2001) 2958-2965
69. Beenken K.E., et al. Global gene expression in Staphylococcus aureus biofilms. J. Bacteriol. 186 (2004) 4665-4684
70. B is involved in regulation of biofilm expression in a Staphylococcus aureus mucosal isolate. J. Bacteriol. 182 (2000) 6824-6826